Skip to main content

Table 2 Comparison of main signs and symptoms between survivors and non-survivors patients with visceral leishmaniasis

From: Hyponatremia and risk factors for death in human visceral leishmaniasis: new insights from a cross-sectional study in Brazil

 

Non-survivors (N = 34)

Survivors (N = 251)

p

Fever

30 (88.2%)

229 (91.2%)

0.569

Hepato-splenomegaly

22 (64.7%)

199 (79.3%)

0.056

Weight loss

22 (64.7%)

185 (74%)

0.253

Asthenia

16 (47.1%)

156 (62.2%)

0.091

Cough

13 (38.2%)

95 (37.8%)

0.965

Abdominal pain

15 (44.1%)

84 (33.5%)

0.221

Diarrhea

12(35.3%)

57 (22.7%)

0.108

Vomiting

13 (38.2%)

54 (21.5%)

0.031

Dyspnea

13 (38.2%)

42 (16.7%)

0.003

Edema

11 (32.4%)

42 (16.7%)

0.028

Jaundice

16 (47.1%)

36 (14.3%)

<0.001

Dehydration

8 (23.5%)

27 (10.8%)

0.033

Nose bleeding

11 (4.8%)

13 (5.2%)

0.128

Pulmonary crackles

4 (11.8%)

10 (4.0%)

0.049

Oliguria

3 (8.8%)

2 (0.8%)

0.001

Hypotension

0 (0%)

2 (0.8%)

0.602

  1. Chi-squared test was used. P ≤ 0.05 was considered statistically significant